Dan Popovici-Toma

Dr. Dan Popovici-Toma has over 25 years of experience in the pharmaceutical and biotechnology fields, hospital settings and strategic consultancy. He worked as a Medical and Scientific Advisor for companies such as Sanofi, Valeant, BioK+, covering a broad array of therapeutic areas including cardiovascular and metabolism, sleep/CNS, allergy, dermatology, oncology, infectious diseases.

Dan’s key area of expertise is the full integration of clinical development into drug life-cycle management from pre-launch, launch and LOE, capitalizing on clinical unmet medical need and developing strategic alliances with various health care stakeholders. He has an extensive clinical trials experience, from study design inception to clinical trial execution.

Dan obtained his MD from “Carol Davila” University of Medicine Bucharest, Romania and specialised in Infectious Diseases. He is also a dedicated Institutional Review Board (IRB) member.